Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

Table 2 Univariate analysis between survived and deceased patients at 90 d

Variables	Survived (n = 22)	Deceased (n = 30)	P
Demographic
Age (yr)	41 ± 9	44 ± 11	0.27
Alcohol consumption per day (g/d)	284 ± 148	303 ± 143	0.584
Male, n (%)	21 (95)	27 (90)	0.94
Laboratory parameters at admission
White blood cell counts (103 /μL)	284 ± 148	303 ± 143	0.584
Glucose (mg/dL)	108 ± 59	99 ± 49	0.55
Sodium (mmol/L)	133 ± 5	129 ± 6	0.03a
Total bilirubin (mg/dL)	16 ± 8	22 ± 10	0.009a
AST (IU/L)	192 ± 137	177 ± 84	0.61
ALT (IU/L)	103 ± 150	67 ± 39	0.24
γGT (IU/L)	577 ± 656	399 ± 480	0.29
Alkaline phosphatase (IU/L)	281 ± 91	211 ± 105	0.01a
Creatinine (mg/dL)	2 ± 1.8	3 ± 2.11	0.01a
INR	2 ± 0.4	3 ± 1.3	0.002a
Prothrombin time (s)	19 ± 4	28 ± 12	0.0003a
Albumin (mg/dL)	3 ± 0.5	3 ± 5	0.54
Cholesterol (mg/dL)	176 ± 90	119 ± 51	0.01a
Triglycerides (mg/dL)	240 ± 163	226 ± 162	0.76
Calcium (mg/dL)	7.9 ± 0.8	7.3 ± 1.5	0.28
Clinical manifestations at admission
Ascites, n (%)	19 (86)	28 (93)	0.71
Child status			0.05a
Grade B, n (%)	8 (37)	3 (10)
Grade C, n (%)	14 (63)	27 (90)
Encephalophaty, n (%)	0 (0)
None	10 (45)	0 (30)	0.106
Stage I	8 (37)	3 (10)
Stage II	4 (18)	19(63)
Stage III		8 (26)
Hepatorrenal syndrome, n (%)	5 (22)	16 (53)	0.05a
Severity of liver disease at admission
MELD-Na score	24.95 ± 8	30.9 ± 7.79	0.01a
Maddrey DFI	68.5 ± 42	88.3 ± 48.6	0.12
MELD	22.1 ± 7.5	23.1 ± 3.1	0.28

^aP < 0.05 vs survived patients at 90 d. MELD: Model for end-stage liver disease; DFI: Discrimination function index; INR: International normalized ratio; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; γGT: Gamma glutamyl transpeptidase.